These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27748860)

  • 21. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
    Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
    Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
    J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages.
    Kim AR; Kim HS; Lee JM; Choi JH; Kim SN; Kim DK; Kim JH; Mun SH; Kim JW; Jeon HS; Kim YM; Choi WS
    Eur J Pharmacol; 2012 May; 682(1-3):29-36. PubMed ID: 22387094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of macrophage inhibitory cytokine-1 in RPMI-8226 human multiple myeloma cells inhibits osteoclastic differentiation through inhibiting the RANKL-Erk1/2 signaling pathway.
    Yuan M; Chen J; Zeng Z
    Mol Med Rep; 2016 Dec; 14(6):5199-5204. PubMed ID: 27779672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration.
    Ntumba K; Akla N; Oh SP; Eichmann A; Larrivée B
    Oncotarget; 2016 Aug; 7(35):55957-55969. PubMed ID: 27517154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.
    Subramaniam M; Gorny G; Johnsen SA; Monroe DG; Evans GL; Fraser DG; Rickard DJ; Rasmussen K; van Deursen JM; Turner RT; Oursler MJ; Spelsberg TC
    Mol Cell Biol; 2005 Feb; 25(3):1191-9. PubMed ID: 15657444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-κB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-κB-induced RAW264.7 cells.
    Wang X; Zhu Y; Zheng S; Ni C; Zhao L; Liu C; Chen A; Xiao J
    Mol Med Rep; 2015 May; 11(5):3451-6. PubMed ID: 25592168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL-induced osteoclastogenesis.
    Hu Y; Hao X; Liu C; Ren C; Wang S; Yan G; Meng Y; Mishina Y; Shi C; Sun H
    J Cell Physiol; 2021 Jun; 236(6):4580-4591. PubMed ID: 33251612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
    Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
    J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone morphogenetic proteins signal via SMAD and mitogen-activated protein (MAP) kinase pathways at distinct times during osteoclastogenesis.
    Broege A; Pham L; Jensen ED; Emery A; Huang TH; Stemig M; Beppu H; Petryk A; O'Connor M; Mansky K; Gopalakrishnan R
    J Biol Chem; 2013 Dec; 288(52):37230-40. PubMed ID: 24235143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
    Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
    Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis.
    Somekawa S; Imagawa K; Hayashi H; Sakabe M; Ioka T; Sato GE; Inada K; Iwamoto T; Mori T; Uemura S; Nakagawa O; Saito Y
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12064-9. PubMed ID: 22783020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells.
    Hou GQ; Guo C; Song GH; Fang N; Fan WJ; Chen XD; Yuan L; Wang ZQ
    Int J Mol Med; 2013 Aug; 32(2):503-10. PubMed ID: 23740407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone morphogenetic protein 9 serves a protective role in response to ischemic‑reperfusion in the brain by promoting ERK activation.
    Feng Y; Hu Y
    Mol Med Rep; 2018 Feb; 17(2):2845-2852. PubMed ID: 29257291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
    van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
    J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-mediated expression of bone morphogenetic protein-2 activates titanium particle-induced osteoclastogenesis and this effect occurs in spite of the suppression of TNF-α expression by siRNA.
    Sun S; Guo H; Zhang J; Yu B; Sun K; Jin Q
    Int J Mol Med; 2013 Aug; 32(2):403-9. PubMed ID: 23708523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway.
    Ihn HJ; Lee D; Lee T; Kim SH; Shin HI; Bae YC; Hong JM; Park EK
    PLoS One; 2015; 10(11):e0142201. PubMed ID: 26536233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.